{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:01:28Z","timestamp":1772240488161,"version":"3.50.1"},"reference-count":236,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.neuroscience.2025.04.012","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:54:55Z","timestamp":1744149295000},"page":"83-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["microRNAs as molecular tools for brain health: Neuroprotective potential in neurodegenerative disorders"],"prefix":"10.1016","volume":"574","author":[{"given":"Mozhgan","family":"Abasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anvarsadat","family":"Kianmehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0061-6860","authenticated-orcid":false,"given":"Athena","family":"Variji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Sangali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdolkarim","family":"Mahrooz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.04.012_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114154","article-title":"MicroRNA-124 attenuates PTSD-like behaviors and reduces the level of inflammatory cytokines by downregulating the expression of TRAF6 in the hippocampus of rats following single-prolonged stress","volume":"356","author":"Chen","year":"2022","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0010","first-page":"1309","article-title":"MicroRNAs in neuronal communication","volume":"49","author":"Higa","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MOL.0000000000000687","article-title":"Epigenetics of paraoxonases","volume":"31","author":"Mahrooz","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b1065","doi-asserted-by":"crossref","first-page":"1336439","DOI":"10.3389\/fncel.2024.1336439","article-title":"MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line","volume":"18","author":"Perdaens","year":"2024","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yexcr.2013.09.022","article-title":"miRNAs in brain development","volume":"321","author":"Petri","year":"2014","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0025","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1124\/mol.111.076166","article-title":"MicroRNA 335 is required for differentiation of malignant glioma cells induced by activation of cAMP\/protein kinase A pathway","volume":"81","author":"Shu","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0030","first-page":"1","author":"Kianmehr","year":"2021","journal-title":"Oxidized LDL-Regulated microRNAs for Evaluating Vascular Endothelial Function: Molecular Mechanisms and Potential Biomarker Roles in Atherosclerosis. Critical Reviews in Clinical Laboratory Sciences."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0040","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/nar\/gkq832","article-title":"MiRNA\u2013miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features","volume":"39","author":"Xu","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0045","doi-asserted-by":"crossref","DOI":"10.18502\/ijaai.v19i6.4930","article-title":"Epigallocatechin-3-gallate Enhances the Efficacy of MicroRNA-34a Mimic and MiR-93 Inhibitor Co-transfection in Prostate Cancer Cell Line","author":"Mokhtari","year":"2020","journal-title":"Iran. J. Allergy Asthma Immunol."},{"issue":"50","key":"10.1016\/j.neuroscience.2025.04.012_b0050","doi-asserted-by":"crossref","first-page":"38951","DOI":"10.1074\/jbc.M110.178848","article-title":"Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-\u03baB in stressed human astroglial cells and in Alzheimer disease","volume":"285","author":"Cui","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.expneurol.2011.10.031","article-title":"Targeting microRNAs in neurons: tools and perspectives","volume":"235","author":"Ruberti","year":"2012","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/STROKEAHA.116.013650","article-title":"Circulating microRNAs as novel biomarkers of stenosis progression in asymptomatic carotid stenosis","volume":"48","author":"Dolz","year":"2017","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.04.012_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2017.03.001","article-title":"miR-219 cooperates with miR-338 in myelination and promotes myelin repair in the CNS","volume":"40","author":"Wang","year":"2017","journal-title":"Dev. Cell"},{"issue":"8","key":"10.1016\/j.neuroscience.2025.04.012_b0070","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1515\/cclm-2022-1286","article-title":"SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections","volume":"61","author":"Mimmi","year":"2023","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.04.012_b0075","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1007\/s12035-019-1632-0","article-title":"Addressing Alzheimer\u2019s disease (AD) neuropathology using anti-microRNA (AM) strategies","volume":"56","author":"Jaber","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0080","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.3390\/ijms25042255","article-title":"Multiple Sclerosis: Roles of miRNA, lcnRNA, and circRNA and Their Implications in Cellular Pathways","volume":"25","author":"Cipriano","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.04.012_b0085","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1152\/physiolgenomics.00168.2010","article-title":"MicroRNA in central nervous system trauma and degenerative disorders","volume":"43","author":"Liu","year":"2011","journal-title":"Physiol. Genomics"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuron.2013.10.062","article-title":"Transcriptome-wide discovery of microRNA binding sites in human brain","volume":"81","author":"Boudreau","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12017-009-8065-2","article-title":"microRNA regulation of synaptic plasticity","volume":"11","author":"Smalheiser","year":"2009","journal-title":"NeuroMol. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1100\/tsw.2007.196","article-title":"MicroRNAs in vertebrate synapse development","volume":"7","author":"Fiore","year":"2007","journal-title":"Scientific World Journal"},{"issue":"23","key":"10.1016\/j.neuroscience.2025.04.012_b0105","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.3390\/ijms20236055","article-title":"Interplay between MicroRNAs and oxidative stress in neurodegenerative diseases","volume":"20","author":"Konovalova","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0110","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/CEJ.0000000000000645","article-title":"Role of microRNAs in the anticancer effects of the flavonoid luteolin: a systematic review","volume":"30","author":"Mishan","year":"2021","journal-title":"Eur. J. Cancer Prev."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.04.012_b0115","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrn2763","article-title":"microRNAs at the synapse","volume":"10","author":"Schratt","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.04.012_b0120","article-title":"GSK3 and miRNA in neural tissue: From brain development to neurodegenerative diseases. Biochimica et Biophysica Acta (BBA)-Molecular","volume":"1867","author":"Gizak","year":"2020","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tins.2008.12.003","article-title":"Alterations of the microRNA network cause neurodegenerative disease","volume":"32","author":"H\u00e9bert","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2006-7-9-r85","article-title":"Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression","volume":"7","author":"Wu","year":"2006","journal-title":"Genome Biol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0135","doi-asserted-by":"crossref","unstructured":"F\u00e9nelon K, Mukai J, Xu B, Hsu P-K, Drew LJ, Karayiorgou M, et al. Deficiency of Dgcr8, a gene disrupted by the 22q11. 2 microdeletion, results in altered short-term plasticity in the prefrontal cortex. Proceedings of the National Academy of Sciences. 2011;108(11):4447-52.","DOI":"10.1073\/pnas.1101219108"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1749-8104-6-11","article-title":"Monoallelic deletion of the microRNA biogenesis gene Dgcr8 produces deficits in the development of excitatory synaptic transmission in the prefrontal cortex","volume":"6","author":"Schofield","year":"2011","journal-title":"Neural Dev."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.04.012_b0145","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamaneurol.2013.3646","article-title":"Association between early-onset Parkinson disease and 22q11. 2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications","volume":"70","author":"Butcher","year":"2013","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.04.012_b0150","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ijdevneu.2012.08.002","article-title":"Dicer is essential for neuronal polarity","volume":"30","author":"Li","year":"2012","journal-title":"Int. J. Dev. Neurosci."},{"issue":"14","key":"10.1016\/j.neuroscience.2025.04.012_b0155","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1073\/pnas.0801689105","article-title":"Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration","volume":"105","author":"Cuellar","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035921","article-title":"Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis","volume":"7","author":"McKiernan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02191-2","article-title":"Transcriptional factor FoxM1-activated microRNA-335-3p maintains the self-renewal of neural stem cells by inhibiting p53 signaling pathway via Fmr1","volume":"12","author":"Jia","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.04.012_b0170","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/onc.2014.75","article-title":"Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2","volume":"34","author":"Wang","year":"2015","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0175","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1073\/pnas.0908750107","article-title":"MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX signaling","volume":"107","author":"Zhao","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0180","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/bib\/bbz032","article-title":"MicroRNAs and nervous system diseases: Network insights and computational challenges","volume":"21","author":"Wang","year":"2020","journal-title":"Brief. Bioinform."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms13616","article-title":"Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment","volume":"7","author":"Katsushima","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2015.06.136","article-title":"MicroRNA deregulation in symptomatic carotid plaque","volume":"62","author":"Maitrias","year":"2015","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0195","article-title":"Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications","volume":"1\u201312","author":"Kianmehr","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"05","key":"10.1016\/j.neuroscience.2025.04.012_b0200","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1160\/TH16-08-0606","article-title":"Distinctive expression signatures of serum microRNAs in ischaemic stroke and transient ischaemic attack patients","volume":"117","author":"Wu","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.04.012_b0205","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1089\/neu.2016.4857","article-title":"MicroRNAs as novel biomarkers for the diagnosis and prognosis of mild and severe traumatic brain injury","volume":"34","author":"Di Pietro","year":"2017","journal-title":"J. Neurotrauma"},{"issue":"7","key":"10.1016\/j.neuroscience.2025.04.012_b0210","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.0000000000001258","article-title":"Overexpression of blood microRNAs 103a, 30b, and 29a in l-dopa\u2013treated patients with PD","volume":"84","author":"Serafin","year":"2015","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2025.04.012_b0215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jns.2014.01.006","article-title":"The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 192Q\/R phenotypes","volume":"338","author":"Mahrooz","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0220","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/cells13040340","article-title":"Salivary Biomarkers for Parkinson\u2019s Disease: A Systematic Review with Meta-Analysis","volume":"13","author":"Nijakowski","year":"2024","journal-title":"Cells."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124555","article-title":"miR-141 and miR-200a, revelation of new possible players in modulation of Th17\/Treg differentiation and pathogenesis of multiple sclerosis","volume":"10","author":"Naghavian","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0230","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/ejn.16207","article-title":"miR\u2010221 and Parkinson's disease: A biomarker with therapeutic potential","volume":"59","author":"Zamanian","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116029","article-title":"Mechanisms of microRNA-132 in central neurodegenerative diseases: A comprehensive review","volume":"170","author":"Mu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuro.2024.02.005","article-title":"Neuronal exosomal miRNAs modulate mitochondrial functions and cell death in bystander neuronal cells under Parkinson\u2019s disease stress conditions","author":"Currim","year":"2024","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0245","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nm.2266","article-title":"MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C\/EBP-\u03b1\u2013PU. 1 pathway","volume":"17","author":"Ponomarev","year":"2011","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-021-01186-7","article-title":"VISTA regulates microglia homeostasis and myelin phagocytosis, and is associated with MS lesion pathology","volume":"9","author":"Borggrewe","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030832","article-title":"MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state","volume":"7","author":"Saba","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0260","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neuron.2010.02.018","article-title":"MicroRNA-mediated control of oligodendrocyte differentiation","volume":"65","author":"Zhao","year":"2010","journal-title":"Neuron"},{"issue":"13","key":"10.1016\/j.neuroscience.2025.04.012_b0265","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1242\/dev.050633","article-title":"Control of oligodendroglial cell number by the miR-17-92 cluster","volume":"137","author":"Budde","year":"2010","journal-title":"Development"},{"issue":"15","key":"10.1016\/j.neuroscience.2025.04.012_b0270","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1523\/JNEUROSCI.5178-12.2013","article-title":"Sox10 cooperates with the mediator subunit 12 during terminal differentiation of myelinating glia","volume":"33","author":"Vogl","year":"2013","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0275","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/22123946MTA33NzUey","article-title":"Transplantation of stem cells as a potential therapeutic strategy in neurodegenerative disorders","volume":"16","author":"Ebrahimi","year":"2021","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuint.2014.06.010","article-title":"MicroRNA and transcriptional crosstalk in myelinating glia","volume":"77","author":"Svaren","year":"2014","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.22166","article-title":"Charcot\u2010Marie\u2010Tooth disease subtypes and genetic testing strategies","volume":"69","author":"Saporta","year":"2011","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.04.012_b0290","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.3390\/ijms23073440","article-title":"How miRNAs regulate schwann cells during peripheral nerve regeneration\u2014A systemic review","volume":"23","author":"Borger","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0295","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/jcp.29910","article-title":"MiRNA\u2010145\u20105p prevents differentiation of oligodendrocyte progenitor cells by regulating expression of myelin gene regulatory factor","volume":"236","author":"Kornfeld","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0300","doi-asserted-by":"crossref","first-page":"57","DOI":"10.32604\/biocell.2021.011756","article-title":"MiR-494-3p regulates cell proliferation and apoptosis via KLF7 in Schwann cells","volume":"45","author":"Peng","year":"2021","journal-title":"Biocell"},{"issue":"10","key":"10.1016\/j.neuroscience.2025.04.012_b0305","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00018-021-03802-0","article-title":"Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders","volume":"78","author":"Spaas","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.04.012_b0310","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ana.21927","article-title":"Dicer ablation in oligodendrocytes provokes neuronal impairment in mice","volume":"66","author":"Shin","year":"2009","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.04.012_b0315","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nn.2323","article-title":"Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity","volume":"12","author":"Woodhoo","year":"2009","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0320","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1038\/s41598-018-22010-8","article-title":"Egr2-dependent microRNA-138 is dispensable for peripheral nerve myelination","volume":"8","author":"Lin","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.04.012_b0325","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/dneu.22848","article-title":"Functions of noncoding RNAs in glial development","volume":"81","author":"Wu","year":"2021","journal-title":"Dev. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.09.020","article-title":"Oligodendrocyte intrinsic miR-27a controls myelination and remyelination","volume":"29","author":"Tripathi","year":"2019","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0335","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuron.2010.01.027","article-title":"Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination","volume":"65","author":"Dugas","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00982","article-title":"Egr2 overexpression in Schwann cells increases myelination frequency in vitro","volume":"4","author":"Tammia","year":"2018","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0345","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1017\/S1740925X08000173","article-title":"Interactions of Sox10 and Egr2 in myelin gene regulation","volume":"3","author":"Jones","year":"2007","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0640","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuroscience.2012.07.009","article-title":"The synergistic effect of beta-boswellic acid and Nurr1 overexpression on dopaminergic programming of antioxidant glutathione peroxidase-1-expressing murine embryonic stem cells","volume":"222","author":"Abasi","year":"2012","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.neuroscience.2025.04.012_b0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039674","article-title":"Combinatorial action of miRNAs regulates transcriptional and post-transcriptional gene silencing following in vivo PNS injury","volume":"7","author":"Adilakshmi","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0355","doi-asserted-by":"crossref","first-page":"8584","DOI":"10.1038\/ncomms9584","article-title":"The Lin28\/let-7 axis is critical for myelination in the peripheral nervous system","volume":"6","author":"G\u00f6kbuget","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010480","article-title":"MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells","volume":"5","author":"Letzen","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0365","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1523\/JNEUROSCI.4178-07.2008","article-title":"A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function","volume":"28","author":"Cahoy","year":"2008","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0370","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00401-017-1741-7","article-title":"Myelin regulatory factor drives remyelination in multiple sclerosis","volume":"134","author":"Duncan","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0375","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/ejn.13485","article-title":"miR\u2010219 attenuates demyelination in cuprizone\u2010induced demyelinated mice by regulating monocarboxylate transporter 1","volume":"45","author":"Liu","year":"2017","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0380","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/acn3.750","article-title":"Expression of disease\u2010related mi RNA s in white\u2010matter lesions of progressive multiple sclerosis brains","volume":"6","author":"Tripathi","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0385","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2017.02.029","article-title":"MiR-146a promotes remyelination in a cuprizone model of demyelinating injury","volume":"348","author":"Zhang","year":"2017","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0390","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1523\/JNEUROSCI.1240-15.2016","article-title":"Remyelinating oligodendrocyte precursor cell miRNAs from the Sfmbt2 cluster promote cell cycle arrest and differentiation","volume":"36","author":"Kuypers","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1208-y","article-title":"A critical role for miR-184 in the fate determination of oligodendrocytes","volume":"10","author":"Afrang","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"15","key":"10.1016\/j.neuroscience.2025.04.012_b0400","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1091\/mbc.e12-04-0270","article-title":"Specification and maintenance of oligodendrocyte precursor cells from neural progenitor cells: involvement of microRNA-7a","volume":"23","author":"Zhao","year":"2012","journal-title":"Mol. Biol. Cell"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0405","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrn3722","article-title":"Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease","volume":"15","author":"Prinz","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0410","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3389\/fimmu.2018.00490","article-title":"Experimental demyelination and axonal loss are reduced in MicroRNA-146a deficient mice","volume":"9","author":"Martin","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0415","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nbd.2019.01.019","article-title":"MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis","volume":"125","author":"Zhang","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0420","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/glia.23576","article-title":"miR\u2010223 promotes regenerative myeloid cell phenotype and function in the demyelinated central nervous system","volume":"67","author":"Galloway","year":"2019","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0425","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/15548627.2018.1522467","article-title":"Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1","volume":"15","author":"Li","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0430","unstructured":"Fang X, Sun D, Wang Z, Yu Z, Liu W, Pu Y, et al., editors. MiR-30a Positively Regulates the Inflammatory Response of Microglia in EAE. \u4e2d\u56fd\u795e\u7ecf\u79d1\u5b66\u5b66\u4f1a\u7b2c\u5341\u4e8c\u5c4a\u5168\u56fd\u5b66\u672f\u4f1a\u8bae\u8bba\u6587\u96c6; 2017."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0435","doi-asserted-by":"crossref","unstructured":"Maciak K, Dziedzic A, Miller E, Saluk-Bijak J. miR-155 as an important regulator of multiple sclerosis pathogenesis. A review. International journal of molecular sciences. 2021;22(9):4332.","DOI":"10.3390\/ijms22094332"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0440","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fnmol.2019.00125","article-title":"MicroRNAs in microglia: how do microRNAs affect activation, inflammation, polarization of microglia and mediate the interaction between microglia and glioma?","volume":"12","author":"Guo","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212039","article-title":"miRNA expression profiles and molecular networks in resting and LPS-activated BV-2 microglia\u2014Effect of cannabinoids","volume":"14","author":"Juknat","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0450","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.drudis.2018.01.011","article-title":"Astrocytes as targets for drug discovery","volume":"23","author":"Gorshkov","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.neuroscience.2025.04.012_b0455","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.jmb.2019.12.041","article-title":"Autophagy in astrocytes and its implications in neurodegeneration","volume":"432","author":"Sung","year":"2020","journal-title":"J. Mol. Biol."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.04.012_b0460","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/jnen\/nlz098","article-title":"Astrocytes in the pathogenesis of multiple sclerosis: an in situ microRNA study","volume":"78","author":"Rao","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0465","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fncel.2020.00078","article-title":"Dissecting the dual role of the glial scar and scar-forming astrocytes in spinal cord injury","volume":"14","author":"Yang","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0470","doi-asserted-by":"crossref","unstructured":"Wheeler MA, Quintana FJ. Regulation of astrocyte functions in multiple sclerosis. Cold Spring Harbor perspectives in medicine. 2019;9(1).","DOI":"10.1101\/cshperspect.a029009"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0475","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/glia.23556","article-title":"The formation of a glial scar does not prohibit remyelination in an animal model of multiple sclerosis","volume":"67","author":"Haindl","year":"2019","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.04.012_b0480","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/acn3.414","article-title":"Effects of fumarates on inflammatory human astrocyte responses and oligodendrocyte differentiation","volume":"4","author":"Galloway","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.04.012_b0485","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1093\/brain\/awp300","article-title":"MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47","volume":"132","author":"Junker","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0490","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12031-019-01294-z","article-title":"Expression profile of selected microRNAs in the peripheral blood of multiple sclerosis patients: A multivariate statistical analysis with ROC curve to find new biomarkers for fingolimod","volume":"68","author":"Eftekharian","year":"2019","journal-title":"J. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0495","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/genes15040402","article-title":"Myelin-Specific microRNA-23a\/b Cluster Deletion Inhibits Myelination in the Central Nervous System during Postnatal Growth and Aging","volume":"15","author":"Ishibashi","year":"2024","journal-title":"Genes"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.04.012_b0500","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/ejn.14337","article-title":"Epigenetic regulation of myelination in health and disease","volume":"49","author":"Lu","year":"2019","journal-title":"Eur. J. Neurosci."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.04.012_b0505","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/glia.20846","article-title":"Peripheral myelin protein 22 is regulated post\u2010transcriptionally by miRNA\u201029a","volume":"57","author":"Verrier","year":"2009","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0510","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1602\/neurorx.2.3.395","article-title":"Animal models of neurological disorders","volume":"2","author":"Chesselet","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0515","doi-asserted-by":"crossref","unstructured":"Cheng \u00e1, Doecke JD, Sharples R, Villemagne VL, Fowler CJ, Rembach A, et al. Prognostic serum miRNA biomarkers associated with Alzheimer\u2019s disease shows concordance with neuropsychological and neuroimaging assessment. Molecular psychiatry. 2015;20(10):1188-96.","DOI":"10.1038\/mp.2014.127"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0520","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.2147\/NDT.S311183","article-title":"Repetitive Transcranial Magnetic Stimulation Improves Mild Cognitive Impairment Associated with Alzheimer\u2019s Disease in Mice by Modulating the miR-567\/NEUROD2\/PSD95 Axis","volume":"17","author":"Pang","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.04.012_b0525","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1007\/s12035-018-1015-y","article-title":"Bacteroidetes neurotoxins and inflammatory neurodegeneration","volume":"55","author":"Zhao","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114026","article-title":"Exosomal microRNAs have great potential in the neurorestorative therapy for traumatic brain injury","volume":"352","author":"Yang","year":"2022","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.04.012_b0535","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3390\/cells9061443","article-title":"MiRNA profiling in plasma neural-derived small extracellular vesicles from patients with Alzheimer\u2019s disease","volume":"9","author":"Serpente","year":"2020","journal-title":"Cells."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0540","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3233\/ADR-210311","article-title":"Altered cerebrospinal fluid exosomal microRNA levels in young-onset Alzheimer\u2019s disease and frontotemporal dementia","volume":"5","author":"Tan","year":"2021","journal-title":"Journal of Alzheimer's Disease Reports."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120395","article-title":"Temporal variability of serum miR-191, miR-223, miR-128, and miR-24 in multiple sclerosis: A 4-year follow-up study","volume":"442","author":"Vistbakka","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113864","article-title":"Detection of multiplex exosomal miRNAs for clinically accurate diagnosis of Alzheimer\u2019s disease using label-free plasmonic biosensor based on DNA-Assembled advanced plasmonic architecture","volume":"199","author":"Song","year":"2022","journal-title":"Biosens. Bioelectron."},{"issue":"23","key":"10.1016\/j.neuroscience.2025.04.012_b0555","doi-asserted-by":"crossref","first-page":"13136","DOI":"10.3390\/ijms222313136","article-title":"Targeting MicroRNA-485-3p blocks Alzheimer\u2019s disease progression","volume":"22","author":"Koh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0560","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1007\/s11095-011-0608-1","article-title":"Subcellular fate and off-target effects of siRNA, shRNA, and miRNA","volume":"28","author":"Singh","year":"2011","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0565","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neurobiolaging.2013.08.003","article-title":"miR128 up-regulation correlates with impaired amyloid \u03b2 (1-42) degradation in monocytes from patients with sporadic Alzheimer's disease","volume":"35","author":"Tiribuzi","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0570","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fnagi.2016.00140","article-title":"Over-expressed pathogenic miRNAs in Alzheimer\u2019s disease (AD) and prion disease (PrD) drive deficits in TREM2-mediated A\u03b242 peptide clearance","volume":"8","author":"Zhao","year":"2016","journal-title":"Front. Aging Neurosci."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.04.012_b0575","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE isoform\u2013specific disruption of amyloid \u03b2 peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0580","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.04.012_b0585","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/gps.4881","article-title":"The microRNA\u20101908 up\u2010regulation in the peripheral blood cells impairs amyloid clearance by targeting ApoE","volume":"33","author":"Wang","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0590","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1471-4159.2010.07097.x","article-title":"In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs","volume":"116","author":"Smith","year":"2011","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.neuroscience.2025.04.012_b0595","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.3390\/nu15173688","article-title":"Modulation of microRNAs through Lifestyle Changes in Alzheimer\u2019s Disease","volume":"15","author":"Pinto-Hernandez","year":"2023","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.04.012_b0600","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/jpm11121275","article-title":"MicroRNA-Target Interaction Regulatory Network in Alzheimer\u2019s Disease","volume":"11","author":"Turk","year":"2021","journal-title":"Journal of Personalized Medicine."},{"issue":"14","key":"10.1016\/j.neuroscience.2025.04.012_b0605","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/1873-3468.12229","article-title":"Micro RNA\u2010146a represses LRP 2 translation and leads to cell apoptosis in Alzheimer's disease","volume":"590","author":"Zhang","year":"2016","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0610","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1007\/s12035-023-03224-y","article-title":"MicroRNA-650 regulates the pathogenesis of Alzheimer\u2019s Disease through targeting Cyclin-Dependent Kinase 5","volume":"60","author":"Lin","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0615","doi-asserted-by":"crossref","unstructured":"Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proceedings of the National Academy of Sciences. 1996;93(20):11173-8.","DOI":"10.1073\/pnas.93.20.11173"},{"issue":"6762","key":"10.1016\/j.neuroscience.2025.04.012_b0620","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.neuroscience.2025.04.012_b0625","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1523\/JNEUROSCI.22-15-06515.2002","article-title":"Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann\u2013Pick type C murine model","volume":"22","author":"Bu","year":"2002","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0630","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0168-0102(99)00026-7","article-title":"Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain","volume":"34","author":"Lee","year":"1999","journal-title":"Neurosci. Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0635","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0896-6273(01)00268-9","article-title":"Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions","volume":"30","author":"Nguyen","year":"2001","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.04.012_b0645","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0650","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41598-017-02420-w","article-title":"Early-onset mild cognitive impairment in Parkinson\u2019s disease: altered corticopetal cholinergic network","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0655","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/metabo7020022","article-title":"Metabolic investigations of the molecular mechanisms associated with Parkinson\u2019s disease","volume":"7","author":"Powers","year":"2017","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0660","first-page":"22","article-title":"Protective role of microRNA-221 in Parkinson's disease","volume":"119","author":"Li","year":"2018","journal-title":"Bratisl. Lek. Listy"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.04.012_b0665","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3390\/cells10061410","article-title":"Regulatory miRNA\u2013mRNA networks in Parkinson\u2019s disease","volume":"10","author":"Santos-Lobato","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173914","article-title":"Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease","volume":"896","author":"Rezaei","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.04.012_b0675","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","article-title":"RNAi therapeutics: a potential new class of pharmaceutical drugs","volume":"2","author":"Bumcrot","year":"2006","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.04.012_b0680","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrd2310","article-title":"Interfering with disease: a progress report on siRNA-based therapeutics","volume":"6","author":"de Fougerolles","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.04.012_b0685","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/gt.2011.56","article-title":"Special delivery: targeted therapy with small RNAs","volume":"18","author":"Peer","year":"2011","journal-title":"Gene Ther."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.04.012_b0690","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nbt0607-631","article-title":"MicroRNA gets down to business","volume":"25","author":"Mack","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.04.012_b0695","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0700","first-page":"1103","article-title":"Advances with microRNAs in Parkinson\u2019s disease research","author":"Ma","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0705","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/cells9040841","article-title":"The promise and challenges of developing miRNA-based therapeutics for Parkinson\u2019s disease","volume":"9","author":"Titze-de-Almeida","year":"2020","journal-title":"Cells."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0710","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/13543770802680195","article-title":"Delivery of small-interfering RNA (siRNA) to the brain: WO2008033285; 2008","volume":"19","author":"Mathupala","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0715","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2015.10.015","article-title":"Chemical and structural modifications of RNAi therapeutics","volume":"104","author":"Ku","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"14","key":"10.1016\/j.neuroscience.2025.04.012_b0720","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2025.04.012_b0725","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijpharm.2015.01.051","article-title":"Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation","volume":"481","author":"Danhier","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0730","series-title":"Transfection of neuronal cultures","first-page":"133","author":"Sariyer","year":"2013"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0735","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1525-0016(03)00065-0","article-title":"Magnetofection\u2014a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo","volume":"7","author":"Kr\u00f6tz","year":"2003","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0740","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.nano.2015.01.012","article-title":"Enduring high-efficiency in vivo transfection of neurons with non-viral magnetoparticles in the rat visual cortex for optogenetic applications","volume":"11","author":"Soto-S\u00e1nchez","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0745","article-title":"Delivery of miRNA-targeted oligonucleotides in the rat striatum by magnetofection with Neuromag\u00ae","volume":"23(7):1825","author":"Titze de Almeida","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0750","article-title":"Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson\u2019s Disease","volume":"1\u201327","author":"Yadav","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0755","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fnmol.2016.00089","article-title":"Protective microglia and their regulation in Parkinson\u2019s disease","volume":"9","author":"Le","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0760","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuroscience.2014.04.039","article-title":"Downregulation of miR-124 in MPTP-treated mouse model of Parkinson\u2019s disease and MPP iodide-treated MN9D cells modulates the expression of the calpain\/cdk5 pathway proteins","volume":"272","author":"Kanagaraj","year":"2014","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0765","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/jcb.26170","article-title":"The neuroprotective role of MiR\u2010124\u20103p in a 6\u2010hydroxydopamine\u2010induced cell model of Parkinson's disease via the regulation of ANAX5","volume":"119","author":"Dong","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.04.012_b0770","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1096\/fj.201900363R","article-title":"MicroRNA\u2010124 regulates the expression of p62\/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease","volume":"33","author":"Yao","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0775","article-title":"Gender differences in microRNA expression in levodopa-naive PD patients","volume":"1\u20139","author":"Vallelunga","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0780","first-page":"006).","volume":"S37","author":"Schiess","year":"2023","journal-title":"Blood microRNA-7 as a Progression Biomarker in Men with Parkinson's Disease"},{"issue":"17","key":"10.1016\/j.neuroscience.2025.04.012_b0785","doi-asserted-by":"crossref","first-page":"12726","DOI":"10.1074\/jbc.M109.086827","article-title":"Post-transcriptional regulation of \u03b1-synuclein expression by mir-7 and mir-153","volume":"285","author":"Doxakis","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.04.012_b0790","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ymthe.2017.08.017","article-title":"Loss of microRNA-7 regulation leads to \u03b1-synuclein accumulation and dopaminergic neuronal loss in vivo","volume":"25","author":"McMillan","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0795","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fncel.2014.00182","article-title":"miR-7 and miR-153 protect neurons against MPP+-induced cell death via upregulation of mTOR pathway","volume":"8","author":"Fragkouli","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-016-0094-3","article-title":"MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease","volume":"11","author":"Zhou","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.04.012_b0805","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/mds.29515","article-title":"Detection of a Parkinson's Disease\u2013Specific MicroRNA Signature in Nasal and Oral Swabs","volume":"38","author":"Schlie\u00dfer","year":"2023","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0810","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s11658-023-00516-y","article-title":"The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson\u2019s disease","volume":"29","author":"Liang","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0815","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/ane.13288","article-title":"Upregulated serum miR\u2010128\u20103p in progressive and relapse\u2010free multiple sclerosis patients","volume":"142","author":"Zanoni","year":"2020","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0820","doi-asserted-by":"crossref","first-page":"e3489","DOI":"10.1002\/nbm.3489","article-title":"Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping","volume":"30","author":"Guan","year":"2017","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0825","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.631553","article-title":"Circulating microRNAs and long non-coding RNAs as potential diagnostic biomarkers for Parkinson\u2019s disease","volume":"14","author":"Yang","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0830","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neures.2013.09.003","article-title":"Trasferrin receptor 2 gene regulation by microRNA 221 in SH-SY5Y cells treated with MPP+ as Parkinson's disease cellular model","volume":"77","author":"Asci","year":"2013","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107900","article-title":"Neuroprotective effect of crocin against rotenone-induced Parkinson's disease in rats: Interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221","volume":"164","author":"Salama","year":"2020","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0840","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1002\/brb3.2921","article-title":"microRNA\u2010221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease","volume":"13","author":"Yao","year":"2023","journal-title":"Brain and Behavior."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0845","doi-asserted-by":"crossref","unstructured":"Xue X, Bian J-S. Neuroprotective effects of hydrogen sulfide in Parkinson's disease animal models: methods and protocols. Methods in enzymology. 554: Elsevier; 2015. p. 169-86.","DOI":"10.1016\/bs.mie.2014.11.015"},{"issue":"28","key":"10.1016\/j.neuroscience.2025.04.012_b0850","doi-asserted-by":"crossref","first-page":"17401","DOI":"10.1074\/jbc.M114.629808","article-title":"Generation of dopamine neurons from rodent fibroblasts through the expandable neural precursor cell stage","volume":"290","author":"Lim","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0855","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1159\/000430271","article-title":"Allicin protects PC12 cells against 6-OHDA-induced oxidative stress and mitochondrial dysfunction via regulating mitochondrial dynamics","volume":"36","author":"Liu","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2025.04.012_b0860","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000452521","article-title":"Involvement of microRNA-135a-5p in the protective effects of hydrogen sulfide against Parkinson's disease","volume":"40","author":"Liu","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147563","article-title":"MiR-433-3p restrains the proliferation, migration and invasion of glioma cells via targeting SMC4","volume":"1767","author":"You","year":"2021","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0870","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.parkreldis.2012.01.017","article-title":"Fibroblast growth factor 20 (FGF20) polymorphism is a risk factor for Parkinson\u2019s disease in Chinese population","volume":"18","author":"Pan","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0875","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/01616412.2017.1286542","article-title":"Quantitative assessment of the effect of FGF20 rs12720208 variant on the risk of Parkinson\u2019s disease: a meta-analysis","volume":"39","author":"Wang","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0880","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tiv.2017.10.003","article-title":"Manganese exposure: Linking down-regulation of miRNA-7 and miRNA-433 with \u03b1-synuclein overexpression and risk of idiopathic Parkinson's disease","volume":"46","author":"Tarale","year":"2018","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0885","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fncel.2017.00170","article-title":"Reduced circulating levels of miR-433 and miR-133b are potential biomarkers for Parkinson\u2019s disease","volume":"11","author":"Zhang","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0890","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/mds.27935","article-title":"Salivary microR\u2010153 and microR\u2010223 levels as potential diagnostic biomarkers of idiopathic Parkinson's disease","volume":"35","author":"Cressatti","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0895","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.2c00724","article-title":"Neuroprotective microRNA-381 Binds to Repressed Early Growth Response 1 (EGR1) and Alleviates Oxidative Stress Injury in Parkinson\u2019s Disease","author":"Guo","year":"2023","journal-title":"ACS Chem. Nerosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0900","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12967-024-04881-w","article-title":"MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson\u2019s disease","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b0905","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s11064-022-03795-7","article-title":"The Mechanism of SNHG8\/Microrna-421-3p\/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease","volume":"48","author":"Zhou","year":"2023","journal-title":"Neurochem. Res."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.04.012_b0910","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911942","article-title":"A Parkinson's disease Circ RNA s resource reveals a link between circ SLC 8A1 and oxidative stress","volume":"12","author":"Hanan","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0915","article-title":"Understanding the involvement of microRNAs in mitochondrial dysfunction and their role as potential biomarkers and therapeutic targets in Parkinson\u2019s disease","author":"Tryphena","year":"20231","journal-title":"J. Alzheimers Dis."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.04.012_b0920","doi-asserted-by":"crossref","first-page":"543","DOI":"10.14348\/molcells.2016.0050","article-title":"MiR-144-3p and its target gene \u03b2-amyloid precursor protein regulate 1-methyl-4-phenyl-1, 2-3, 6-tetrahydropyridine-induced mitochondrial dysfunction","volume":"39","author":"Li","year":"2016","journal-title":"Mol. Cells"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0925","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.biopha.2015.08.025","article-title":"MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting \u03b1-synuclein expression in MPTP-induced Parkinson\u2019s disease mouse","volume":"74","author":"Wang","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.04.012_b0930","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41419-019-1809-5","article-title":"miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson\u2019s disease","volume":"10","author":"Hu","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104515","article-title":"miR-124 and Parkinson\u2019s disease: A biomarker with therapeutic potential","volume":"150","author":"Angelopoulou","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b0940","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3892\/mmr.2021.12257","article-title":"Expression levels of specific microRNAs are increased after exercise and are associated with cognitive improvement in Parkinson's disease","volume":"24","author":"Da Silva","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0945","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0559-20.2021","article-title":"Fyn knock-down prevents levodopa-induced dyskinesia in a mouse model of parkinson\u2019s disease","volume":"8","author":"Bordone","year":"2021","journal-title":"Eneuro."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b0035","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1002\/jcb.26472","article-title":"Rn7SK small nuclear RNA is involved in neuronal differentiation","volume":"119","author":"Bazi","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0950","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/imr.13024","article-title":"MicroRNA regulation of B cell receptor signaling","volume":"304","author":"Borbet","year":"2021","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0955","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/imr.13029","article-title":"Cell\u2010intrinsic and\u2010extrinsic roles of miRNAs in regulating T cell immunity","volume":"304","author":"Cho","year":"2021","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0960","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/jir.2010.0037","article-title":"New perspectives in MicroRNA regulation of innate immunity","volume":"30","author":"Gantier","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b0965","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cell.2008.12.027","article-title":"MicroRNA control in the immune system: basic principles","volume":"136","author":"Xiao","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0970","article-title":"Multiple sclerosis immunology: the healthy immune system vs the MS immune system","volume":"74(1 Supplement 1):S2\u2013S8","author":"Kasper","year":"2010","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.04.012_b0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08518","article-title":"Immune gene network of neurological diseases: Multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD)","volume":"7","author":"Mukherjee","year":"2021","journal-title":"Heliyon."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0980","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cca.2021.01.020","article-title":"MicroRNA in multiple sclerosis","volume":"516","author":"Gao","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.neuroscience.2025.04.012_b0985","doi-asserted-by":"crossref","DOI":"10.1177\/1759091420981182","article-title":"miRNAs in microglia: Important players in multiple sclerosis pathology","volume":"13","author":"Walsh","year":"2021","journal-title":"ASN Neuro"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b0990","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/ETLS20210164","article-title":"Remyelination: what are the prospects for regenerative therapies in multiple sclerosis?","volume":"5","author":"Moore","year":"2021","journal-title":"Emerging Top. Life Sci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b0995","doi-asserted-by":"crossref","unstructured":"Yong VW. Prospects of repair in multiple sclerosis. Journal of the Neurological Sciences. 2009;277:S16-S8.","DOI":"10.1016\/S0022-510X(09)70006-1"},{"key":"10.1016\/j.neuroscience.2025.04.012_b1000","series-title":"Neurogenesis and neuroplasticity in major depression: Its therapeutic implication","first-page":"157","author":"Bourin","year":"2021"},{"key":"10.1016\/j.neuroscience.2025.04.012_b1005","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.601600","article-title":"Neural stem cell-derived exosomes regulate neural stem cell differentiation through miR-9-Hes1 axis","volume":"9","author":"Yuan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b1010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-021-01110-5","article-title":"Chronic demyelination and axonal degeneration in multiple sclerosis: pathogenesis and therapeutic implications","volume":"21","author":"Simkins","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b1015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yhbeh.2009.06.004","article-title":"Remyelination\u2014An effective means of neuroprotection","volume":"57","author":"Bruce","year":"2010","journal-title":"Horm. Behav."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.04.012_b1020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tins.2010.01.007","article-title":"Epigenetic regulation of oligodendrocyte identity","volume":"33","author":"Liu","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b1025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1134\/S0362119720010144","article-title":"Epigenetic mechanisms of the pathogenesis of multiple sclerosis","volume":"46","author":"Vakhitov","year":"2020","journal-title":"Hum. Physiol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b1030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12031-016-0851-3","article-title":"miR-145 and miR20a-5p potentially mediate pleiotropic effects of interferon-beta through mitogen-activated protein kinase signaling pathway in multiple sclerosis patients","volume":"61","author":"Ehtesham","year":"2017","journal-title":"J. Mol. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2025.04.012_b1035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2013.07.007","article-title":"Dimethyl fumarate regulates histone deacetylase expression in astrocytes","volume":"263","author":"Kalinin","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b1040","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.conb.2010.05.005","article-title":"Transcriptional and post-transcriptional control of CNS myelination","volume":"20","author":"Emery","year":"2010","journal-title":"Curr. Opin. Neurobiol."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b1045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/rme-2020-0125","article-title":"Research progress on the regulatory role of microRNAs in spinal cord injury","volume":"16","author":"Guo","year":"2021","journal-title":"Regen. Med."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.04.012_b1050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/14728222.2018.1535594","article-title":"Let-7 microRNA as a potential therapeutic target with implications for immunotherapy","volume":"22","author":"Gilles","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.04.012_b1055","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020330","article-title":"The microRNA let-7b-5p is negatively associated with inflammation and disease severity in multiple sclerosis","volume":"10","author":"Mandolesi","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b1060","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23555","article-title":"Relation between microRNA\u2010155 and inflammatory mediators in multiple sclerosis","volume":"38","author":"Elsayed","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b1070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-023-02816-8","article-title":"Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study","volume":"20","author":"Gonzalez-Martinez","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2025.04.012_b1075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mce.2016.06.004","article-title":"miR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy","volume":"433","author":"Sun","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b1080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00441-018-2898-7","article-title":"miR-451 elevation relieves inflammatory pain by suppressing microglial activation-evoked inflammatory response via targeting TLR4","volume":"374","author":"Sun","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-1006-3","article-title":"Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS","volume":"14","author":"Bruinsma","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.neuroscience.2025.04.012_b1090","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1093\/brain\/awz245","article-title":"MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis","volume":"142","author":"Morquette","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2025.04.012_b1095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1226130","article-title":"MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study","volume":"14","author":"Zangh\u00ec","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b1100","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1212\/NXI.0000000000000623","article-title":"Elevated levels of miR-181c and miR-633 in the CSF of patients with MS: a validation study","volume":"6","author":"Kramer","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neuroscience.2025.04.012_b1105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1234869","article-title":"Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing\u2013remitting multiple sclerosis patients","volume":"14","author":"Arisi","year":"2023","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.neuroscience.2025.04.012_b1110","doi-asserted-by":"crossref","first-page":"13923","DOI":"10.3390\/ijms241813923","article-title":"Association between the Cytosine Hydroxymethylation and the Expression of microRNA in Multiple Sclerosis in Polish Population","volume":"24","author":"Basak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.04.012_b1115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-023-00478-4","article-title":"In silico prioritisation of microRNA-associated common variants in multiple sclerosis","volume":"17","author":"Fashina","year":"2023","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.neuroscience.2025.04.012_b1120","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1173212","article-title":"Circulating microRNAs correlate with structural and functional MRI parameters in patients with multiple sclerosis","volume":"16","author":"Geiger","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b1125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1590-5","article-title":"Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a\/b in patients with multiple sclerosis and active lesions","volume":"16","author":"Mu\u00f1oz-San Mart\u00edn","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2025.04.012_b1130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molimm.2021.02.008","article-title":"miRNA-467b inhibits Th17 differentiation by targeting eIF4E in experimental autoimmune encephalomyelitis","volume":"133","author":"Wu","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.neuroscience.2025.04.012_b1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578100","article-title":"miR-485 regulates Th17 generation and pathogenesis in experimental autoimmune encephalomyelitis through targeting STAT3","volume":"379","author":"Xue","year":"2023","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b1140","first-page":"277","article-title":"MiR-9-5p and miR-106a-5p dysregulated in CD4+ T-cells of multiple sclerosis patients and targeted essential factors of T helper17\/regulatory T-cells differentiation","volume":"21","author":"Majd","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.04.012_b1145","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/wrna.1120","article-title":"Potential pitfalls in microRNA profiling","volume":"3","author":"Chugh","year":"2012","journal-title":"Wiley Interdiscip. Rev.: RNA"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.04.012_b1150","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1261\/rna.2225110","article-title":"Complexity of the microRNA repertoire revealed by next-generation sequencing","volume":"16","author":"Lee","year":"2010","journal-title":"RNA"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.04.012_b1155","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.bbadis.2017.06.018","article-title":"Challenges in endometriosis miRNA studies\u2014From tissue heterogeneity to disease specific miRNAs","volume":"1863","author":"Saare","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease."},{"issue":"17\u201318","key":"10.1016\/j.neuroscience.2025.04.012_b1160","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/hum.2024.113","article-title":"Advances in MicroRNA therapeutics: From preclinical to clinical studies","volume":"35","author":"Brillante","year":"2024","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.04.012_b1165","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/ijms25031469","article-title":"Trials and tribulations of MicroRNA therapeutics","volume":"25","author":"Seyhan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.04.012_b1170","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.3390\/cancers13112680","article-title":"MicroRNA therapeutics in cancer: current advances and challenges","volume":"13","author":"El Sayed","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.neuroscience.2025.04.012_b1175","doi-asserted-by":"crossref","first-page":"e5553","DOI":"10.7717\/peerj.5553","article-title":"Data challenges of biomedical researchers in the age of omics","volume":"6","author":"Garcia-Milian","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.neuroscience.2025.04.012_b1180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.59543\/ijmscs.v2i.8703","article-title":"A comprehensive review of artificial intelligence approaches in omics data processing: evaluating progress and challenges","volume":"2","author":"Ali","year":"2024","journal-title":"International Journal of Mathematics, Statistics, and Computer Science."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225002891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225002891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T08:12:39Z","timestamp":1745395959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225002891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":236,"alternative-id":["S0306452225002891"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.04.012","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"microRNAs as molecular tools for brain health: Neuroprotective potential in neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}